The IPO Buzz: Seaport Therapeutics Prices Upsized IPO at $18 & Stock Gains 16.7 Percent
Seaport Therapeutics (SPTX), a Boston-based biotech developing drugs to treat major depression, increased its IPO’s size at pricing – to 14.16 million shares – up from 11.8 million in the prospectus – and priced its IPO at $18.00 – the top of its range – to raise $254.88 million on Thursday night, April 30, 2026. Shares of Seaport Therapeutics shot up $3.00 - or 16.67 pe..
Read more May 1, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| C4 Natural Solutions | MTNE | 20.0 | $ 200.0 mil | 5/1/2026 Priced | S/O | S/O |
| Hemab Therapeutics Holdings, Inc. | COAG | 16.8 | $ 301.5 mil | 5/1/2026 Priced | S/O | S/O |
| Quantum Leap Acquisition Corp. | QLEPU | 20.0 | $ 200.0 mil | 5/1/2026 Priced | S/O | S/O |
Last 100 IPOs - May 2, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 47 |
| Number Down: | 49 |
| Number Unchanged: | 4 |
| Percentage Change From Issue Price: | -8.88% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - May 2, 2026
| Number of IPOs priced (Excluding 80 units) : | 55 |
| Number Up: | 27 |
| Number Down: | 27 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | -0.30% |
| The Nasdaq Composite Index YTD % Change | 35.22% |